News & Media

ESCMID Panorama

News in 2012

The forecast looks good for ECCMID 2013. We are putting together an excellent mix of posters, meet-the-expert sessions, symposia, workshops and more. 

IHMA Europe, Epalinges, Switzerland
Training position for a microbiology trainee

The medical societies of India have published a a ”A roadmap to tackle the challenge of antimicrobial resistance” in the "Chennai Declaration". ESCMID applauds their concerted efforts to combat the problem.

The survey focuses on therapeutics areas of uncertainty, such as gentamicin use, oral antibiotic therapy, first-line treatment of MRSA and E. faecalis endocarditis. Thank you for your participation! ... read more here

Read the newsletter from our viral hepatitis experts and become active in this group! Current topics are:

  • Renewal of Executive Committee
  • Renewal of ESGVH membership
  • ESGVH @ ECCMID 2013
  • Future projects and events
21 November 2012
Apply for Study Group Membership now – become active in ESCMID!

Study Group Membership is free for all ESCMID members! For an overview on all topics covered, check out the overview page. To apply go to the Study Group website of interest.

15 November 2012
European Antibiotic Awareness Day

This year 16 November highlights the European Antibiotic Awareness Day. It has the support of all global health organisations, such as WHO, WHO Europe and ECDC, and many societies (e.g. Antibiotic Action by BSAC), including ESCMID. Our dedication to the timely and correct use of antibiotics has long traditions. Since many years, and through our Study Groups such as ESGARS and ESGAP, we involve ourselves strongly in the fight against antimicrobial resistance. We were involved in EARSS and are now in EARS-Net (from ECDC). Together with ECDC, we also drive the important standardisation and harmonisation of susceptibility testing through the European Committee on Antimicrobial Susceptibility Testing EUCAST. More recently, and together with WHO Europe and RIVM (Rijksinstituut voor Volksgezondheid en Milieu, The Netherlands) we recently signed a memmorandum of understanding see here in which the three parties pledge scientific and financial help to European countries outside the EU to set up surveillance of antimicrobial resistance in a similar way to what is done in EARS-Net (the CAESAR project). The ESCMID website and the recently relaunched ESCMID Online Lecture Library attest to the deep involvement in all issues pertaining to the use and misuse of antimicrobials.

14 November 2012
ESCMID, WHO Europe, and MoH/RIVM sign Memorandum on CAESAR project to expand antimicrobial surveillance

On 30 October, WHO/Europe signed an agreement with the National Institute for Public Health and the Environment (RIVM) of the Netherlands, and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) to expand surveillance of antimicrobial resistance to cover all countries in the WHO European Region.

The establishment of this new Central Asia and European Surveillance of Antimicrobial Resistance (CAESAR) network is a key component of the European action plan on antibiotic resistance, agreed by Member States in September 2011.

“This is very strong tripartite collaboration,” stated Zsuzsanna Jakab, WHO Regional Director for Europe, at the signing. “The agreement brings together the partners’ different surveillance capacities: ESCMID for its expertise in diagnostics, RIVM for its expertise in epidemiology and WHO for its country reach and convening powers.”

“We know we can work together, because we have done so for many years,” added Gunnar Kahlmeter, President of ESCMID.

CAESAR’s surveillance work will complement that of the European Centre for Disease Prevention and Control (ECDC) through the European Antimicrobial Resistance Surveillance Network (EARS-Net). To enable comparison of data for the whole European Region, CAESAR will use the EARS-Net methodology in close collaboration with ECDC.

Concluding the signing ceremony, Andre van der Zande, Director-General of RIVM, commented, “RIVM is proud that the efforts that went into developing what is now EARS-Net are also being used to develop CAESAR.”

The increase and spread of bacteria that are resistant to the antibiotics developed to kill them are a major threat to health in the WHO European Region. Mapping antibiotic use and resistance is vital, providing health professionals, risk managers and decision-makers with the evidence they need to prioritize their resources and efforts to contain antibiotic resistance.

New user-friendly search and navigation options make it much easier to find what you are looking for. The latest material is exclusively available for ESCMID members - older material is freely available to the public.

Look and rediscover our wealth of materials in the OLL!

New antimicrobial agents: Breakpoints for ceftaroline, a new cephalosporine with activity against many MRSA, have been released and are available on the EUCAST website. EUCAST disk diffusion breakpoints and QC criteria are also available.   Several other new agents are at various stages in the breakpoint setting process.
Subcommittees: The subcommittee on detection of resistance mechanisms of clinical and/or epidemiological importance has prepared a first draft of a report that should be released for consultation later this year.
Breakpoints: EUCAST breakpoint tables v. 3.0 (2013) are close to completion for release in December 2012.
Methods: QC tables for MIC and disk diffusion methods have been updated and version 2.1 is on the EUCAST website. BioMérieux now state that MH-F is a validated medium for the Etest of fastidious organisms (Streptococci, S. pneumonia and Haemophilus and several others).
Implementation of EUCAST breakpoints in Europe: Based on several sources, the use of EUCAST breakpoints in Europe has increased from 30% of laboratories in 2009 to more than 60 % early in  2012.
Read more

This is the last call for nominations and applications for the ESCMID awards and grants 2013. The deadline is on 12 November 2012, 12.00 CET. ESCMID would be proud to select you among the awardees for the ESCMID Excellence Award, ESCMID Young Investigator Award, TAE Excellence Training Award, and Research Grants. Apply now!

The successful edition of the Manual of Microbiology produced by ESCMID in collaboration with SFM is now available for online purchase on Amazon UK, France and Germany. Picking up your copy of the EMCM is easy as ever. Buy it now!

100 young scientists can apply for a travel grant to attend the 23rd ECCMID in Berlin from 27 to 30 April 2013. Applications must be received online by 29 November 2012. Travel grants are conditional upon the acceptance of an abstract. A full travel grant will include full registration to the congress and a travel allowance. Read more100 young scientists can apply for a travel grant to attend the 23rd ECCMID in Berlin from 27 to 30 April 2013. Applications must be received online by 29 November 2012. Travel grants are conditional upon the acceptance of an abstract. A full travel grant will include full registration to the congress and a travel allowance. Read more

25 - 28 September 2012, Madrid, Spain
The clinical microbiologists and the representatives from National Antimicrobial Committees selected for this workshop gathered together at the Microbiology Department School of Pharmacy of the Complutense University in Madrid, Spain to work and to deepen their knowledge on antimicrobial susceptibility testing and surveillance. During those days the postgraduate course programme went through lectures and practical laboratory sessions aiming at explaining the current process of EUCAST breakpoint definition, at performing antimicrobial susceptibility testing by different techniques, understanding the application of EUCAST expert rules for antimicrobial susceptibility testing, explaining antimicrobial surveillance systems, understanding the importance of breakpoints in antimicrobial resistance surveillance systems. Read more

Humans are heavily colonized by about 100 000 billions of bacteria (1014) and the composition of our microbiota has been shown to be associated with various diseases such as obesity, diabetes, atopic dermatitis, and bacterial vaginosis [1]. The medical importance of our microbiota, which has even been considered as a “human organ”[2], has thus led to a growing number of descriptive studies, mainly comparing the microbiome of healthy and ill individuals. Since the large majority of microbial communities are located in the gut, an especially high number of work tried to define the composition of its core microbiota, as well as to identify specific alterations that might be associated to various pathology such as ulcerative colitis, colorectal cancer, or necrotizing enterocolitis [3-5]. Read more

Editorial:

  • Archaea as emerging, fastidious members of the human microbiota, by M. Drancourt

Reviews:

  • Laboratory tools for detection of archaea in humans, by B. Dridi
  • The domain Archaea in human mucosal surfaces, by F. Matarazzo, A. C Ribeiro, M. Faveri, C. Taddei, M. B. Martinez and M. P. A. Mayer
  • Susceptibility of archaea to antimicrobial agents: applications to clinical microbiology , by S. Khelaifia and M. Drancourt

The 23rd European Congress of Clinical Microbiology and Infectious Diseases will be held in Berlin from 27 to 30 April 2013. Outstanding meet-the-expert sessions, symposia and workshops have been planned. Can't you wait to know more? The ECCMID preliminary programme is now online.

12 September 2012
Call for participation in foundation of the ESCMID Study Group concerning forensic microbiology

Microbiology is an important issue in forensic medicine: sexually transmitted diseases, HIV-fingerprinting, but also autopsy findings in post-mortem samples are issues concerning both disciplines. ESCMID members are called to join this Study Group at his foundation to meet the need of more standardization in these issues. Not only microbiologists, but also forensic pathologists, pediatricians and other interested scientists are more than welcome to help establish a discussion forum where medical guidelines can be defined.
Please contact or .

The 2012 APUA Leadership Award goes to Prof. Roman Kozlov, Director of the Institute of Antimicrobial Chemotherapy, Smolensk State Medical Academy, and President of the ESCMID-affiliated Inter-regional Association for Clinical Microbiology & Antimicrobial Chemotherapy (IACMAC), for his sustained leadership to contain antibiotic resistance in Russia and the adjacent region.
In 2011 the same award went to Prof. Giuseppe Cornaglia and to ESCMID, and we underline the strong and enduring partnership between the two consecutive recipients of the APUA Award for establishing educational initiatives to control antibiotic resistance and improving treatment.

Still few days to register for this course held in Istanbul in November. Hot topics are the increased spreading of infections generated by the growth of travellers all around the world, the necessity of raising awareness, of deepening the knowledge about infections in travellers and of reviewing  the epidemiology, prevention and outcome of these infections. Read more

The deadline to apply for the awards and grants 2013 is expiring on 12 November 2012, 12.00 CET. Nominations and applications are open for the ESCMID Excellence Award, ESCMID Young Investigator Award, TAE Excellence Training Award, and Research Grants. Don’t miss the chance to be one of the awardee! Apply now.

The 4 days programme is just coming to an end today. Morning and late afternoon lectures have been filling the days in Copenhagen with some time leftover for laboratory demonstrations and work. ESCMID Study Group for Biofilms (ESGB) is the organiser of the course focused on medical biofilms with examples from urinary tract infections to cystic fibrosis lung infections. The techniques include setup and running of biofilm flow cell systems, fluorescence in situ hybridisation, various advanced imaging techniques, image analysis, flow cytometry and demonstration of biofilm techniques in experimental animal research. Read more


While epidemics are known to accompany wars, the unintentional involvement of militaries in the spread of pathogens or the emergence ofoutbreaks is less documented. The deployment of soldiers has resulted in several epidemics in civilian populations; for example, the spread of smallpox, pandemic influenza, sexually transmitted infections, malaria,multiresistant bacteria, Panton-Valentine leukocidin-positive Staphylococcus aureus, and, more recently, Vibrio cholerae has been attributed to military deployment and activities. Such soldiers-borne epidemics are favored by lack immunity of militaries against pathogens, inappropriate control measures, lack of supervision, disrespect of health rules and laws, poor compliance with hygiene and preventive measures, crowdedness of military camps, long-range mobility and mixing of troops from different origins. While peacekeeping operations are aimed at helping civilian populations, such soldiers-borne epidemics may have dramatic health and political consequences that could hamper the success of the mission. Therefore, the international organizations and the states that mandate such troops within civilian populations weakened by war or social disorganization, have to ensure an appropriate health screening and support of the soldiers and a close monitoring of potentially epidemic diseases.
To read the full article please login into ESCMID website and then read more on CMI Wiley website.



Aiming at working or working in infection control and hospital epidemiology? This course is for you! Three crucial modules make up the course: Healthcare-associated Infection Prevention and Management Core Module, Applied Infection Control Module and Healthcare-associated Infection Advanced Epidemiology Module. Organisers of the course are the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), The Society for Healthcare Epidemiology of America (SHEA) and the Aesculap Academy. Read more


The Infection Hot Topic of the August issue is Soldiers and epidemics by Rogier Cristoph, Director of Institut Pasteur de Madagascar. 

Following the highlights of the August issue:

August issue editorial

Current outbreak of Staphylococcus aureus, by O. Dumitrescu and G. Lina

August issue reviews

  • USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant Staphylococcus aureus, by G. R. Nimmo
  • Livestock-associated Staphylococcus aureus, by A. C. Fluit
  • Novel and uncommon antimicrobial resistance genes in livestock-associated methicillin-resistant Staphylococcus aureus, by K. Kadlec, A. T. Feßler, T. Hauschild and S. Schwarz

Although you can apply until 12 November 2012, 12.00 CET, why should you wait so long? You can be the winner of the ESCMID Awards 2013, be ambitious and apply right now! Nominations and applications are open for the ESCMID Excellence Award, ESCMID Young Investigator Award, TAE Excellence Training Award, and Research Grants. Read more

The International Society for Infectious Diseases (ISID) is organising the 4th IMED, International Meeting on Emerging Diseases and Surveillance, to be held in Vienna in 2013. ESCMID will partner ISID and organise the session Emerging infectious diseases and novel diagnostic tools.
Some of the planned sessions are: Disease Surveillance, Detection and Reporting and Outbreak Modeling; Vectorborne and Zoonotic Diseases; Foodborne and Waterborne Infections; Infections Related to Travel and Migration of Humans and Animals; Animal Reservoirs for Emerging Pathogens; Agents of Bioterrorism/Biological Warfare; Specific Disease Threats: Pandemic Influenza, Anthrax, C. difficile, Q fever, Rift Valley Fever. Read more


Travel, immigration, food and water transmission, sexually transmitted diseases, global perspective, vaccination, returning travellers are the keywords of the lectures of this ESCMID course, which will be held in November in Istanbul. The globalisation is clearly affecting the possibility of containing infections and so this course aims at increasing awareness of the importance of travel-associated infections, at increasing knowledge about infections in travellers and at reviewing the epidemiology, prevention and outcome of these infections. The registration deadline is 16 September 2012. Read more

Breakpoints: EUCAST breakpoints have been set for ceftaroline, one of few cephalosporines with activity against MRSA. Two other new agents are currently being assessed. Epidemiological Cutoff Values/breakpoints for Campylobacter spp., for Pasteurella multocida and for topical agents are currently going through the EUCAST consultation process and anyone interested in commenting should keep an eye at the EUCAST website. The Antifungal Susceptibility Testing Subcommittee has published breakpoints for voriconazole with Aspergillus spp. Read more

The ESCMID Summer School 2012 started on Saturday 21 July at the Innsbruck Medical University Innsbruck in Austria and will last till Friday 27 July. The intensive educational week dedicated to postgraduate and continuing medical education in the field of clinical microbiology and infectious diseases was opened by Erich Schmutzhard with the lecture Management and prevention of malaria chaired by Cornelia Lass-Flörl. After the opening lecture everyone joined the Welcome Reception as first social event of the week. Read more

The July CMI special issue includes the supplement Microbiome: Deciphering the last human body organ. Guest editors are Andrés Moya, Rafael Canton and Didier Raoult. The supplement features several articles on microbiota and metagenomics and the introduction –The microbiome as a human organ –is written by F. Baquero and C. Nombela.

The Infection Hot Topic of the July issue is Emergence of antibiotic resistance: need for a new paradigm, by J.M. Rolain, R. Canton and G. Cornaglia. The article is now freely available on Wiley website.

Following the themed section of the CMI July issue:

July issue editorial

You can teach old pathogens new tricks: the zoonotic potential of Escherichia coli, Clostridium difficile, Staphylococcus aureus, and enterococci, or from Noah’s Ark to Pandora’s Box, by G. Pappas

July issue reviews

  • Enterococci of animal origin and their significance for public health , by A. M. Hammerum
  • Methicillin-resistant Staphylococcus aureus among companion and food-chain animals: impact of human contacts, by E. Petinaki and I. Spiliopoulou
  • Clostridium difficile infection in the community: a zoonotic disease?, by M. P. M. Hensgens, E. C. Keessen, M. M. Squire, T. V. Riley, M. G. J. Koene, E. de Boer, L. J. A. Lipman and E. J. Kuijper, on behalf of European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridium difficile (ESGCD)
  • Extended-spectrum Beta-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective, by C. Ewers, A. Bethe, T. Semmler, S. Guenther and L. H. Wieler

Call for European specialist societies to affiliate with ESCMID! National societies in Europe may sign an affiliation agreement whose objective is to promote the wider interests of both organisations. ESCMID affiliation shall strengthen the cooperation among the European specialist societies in the field of human infection and foster the advancement of science, education and professional affairs across Europe. Read more

ESCMID has organised outstanding CM/ID conferences throughout Europe. The next three conferences are:

the ESCMID/FEMS Conference 2012 on New Frontiers
in Microbiology and Infection: Hepatitis
held in Villars-sur-Ollon, Switzerland on 7 - 11 October 2012;

the 2nd ESCMID Conference on Invasive Fungal Infections held in Rome, Italy on 16-18 January 2013;

the 2nd ESCMID Conference on The Impact of Vaccines
on Public Health
held in Prague, Czech Republic on 22 - 24 March 2013.

Register early for conferences in 2013 to benefit from fee reductions. Watch the video and participate!

19 July 2012
Awards calls 2013

Have you ever heard of the ESCMID Awards? Would you like to be one of the awardees next year? Nominations and applications are now being accepted for the ESCMID Excellence Award, ESCMID Young Investigator Award, TAE Excellence Training Award, and Research Grants until 12 November 2012, 12.00 CET. We look forward to hearing from you. More information about the purpose, funding, eligibility criteria and application procedures can be found on the ESCMID website.

The ESCMID-SFM Manual of Microbiology is a jointly produced hard-copy publication by ESCMID and SFM. In 2010 a popular French Manual of Microbiology was published by SFM. The new manual is based upon the original French manual, but has been updated and adapted for Europe. There are 52 chapters covering essential information in clinical microbiology.
You can now order the newest edition of the Manual of Microbiology launched at the ECCMID in London in April 2012. The cost for individual copies is EUR 50. A download form to purchase book and a preview of the first 15 pages of the book (.pdf) are available on the ESCMID website. Read more

The Scientific Programme Committee has just assembled the ECCMID 2013 programme and the full ECCMID 2013 preliminary programme will be published in September. In the meantime ESCMID gives you a glimpse behind the scenes by sharing some promising sessions with you: Azole antifungal resistance: an environmental threat to community; Culturomics - the rebirth of microbial culture; Therapeutic choices in the management of Staphylococcus aureus bacteraemia: roles of new and old agent; Epidemiological use of Next Generation Sequencing data; Bet hedging - how bacteria adapt to varying environments; ESCMID/ECMM Guideline: diagnosis and therapy of rare and emerging fungi; Innovative technologies for the diagnosis of parasitic diseases; Current challenges in the management of viral hepatitis.

Do you work or want to work in the field of pharmacokinetics and pharmacodynamics? Increase your knowledge and understanding in this area, register for this ESCMID Postgraduate Technical Workshop by 29 July 2012! Participants’ requirements: a basic understanding of statistics and ideally have some experience with PK/PD. The workshop is co-organised by ESCMID PK/PD of Anti-Infectives Study Group (EPASG), National and Kapodistrian University of Athens and Radboud University Medical Centre of Nijmegen. Read more

One of the main activities of the European Medicines Agency is to make available clear guidance to companies in order to bring medicines such as novel antibacterials to the market to fight antimicrobial resistance. The European Medicines Agency released on 4 July 2012 an addendum to the guideline on the evaluation of medicinal products indicated for treatment of bacterial infections for a six-month public consultation period. The addendum contains further guidance on the requirements for clinical studies related to specific indications and on clinical development programmes for new antibacterial agents targeted against rare or multidrug-resistant pathogens. Read more

ESCMID's president Gunnar Kahlmeter

The President greets you all, ESCMID members and non-members alike. My presidential reign started immediately after ECCMID 2012 in London and will end immediately after ECCMID in Barcelona 2014 when Murat Akova, ID, Ankara, Turkey, takes over. ESCMID has been through some tough times lately. Giuseppe Cornaglia, Verona, Italy, piloted us through the difficult times when ESCMID Switzerland was formed and the old ESCMID dissolved. No details required. We are through and soon everything will be back to normal. What is normal? Read more

All ECCMID participants who aren’t already members may take advantage of a 90-day free ESCMID web access, valid until 15 September, including the following benefits:

  • Full access to all material in the ESCMID Online Lecture Library comprising slides and presentations from ECCMIDs, courses and conferences
  • Receipt of the monthly ESCMID Newsletter by email


By the expiration date of this free trial offer we hope to have convinced you to sign up for ESCMID membership. Read more about all membership benefits.

Call for 30–35 clinical microbiologists with an interest in antimicrobial susceptibility testing and surveillance.
Following an extract of interesting lectures for the course in Madrid:

  • Current situation of European (EUCAST) breakpoints. Gunnar Kahlmeter
  • Clinical implications of breakpoints. Jesus Rodriguez Baño
  • Antimicrobial susceptibility testing: diffusion methods. Gunnar Kahlmeter
  • Antimicrobial susceptibility testing: automatic systems. Rafael Cantón
  • EUCAST expert rules. Rafael Cantón
  • International surveillance systems – promises and problems. Giuseppe Cornaglia
  • The Swedish system for surveillance and early warning. Gunnar Kahlmeter


Apply now, the registration deadline expires on 15 July 2012!

The CMI editor’s choice in May covers an everlasting topic for ESCMID, which is the emergence of antibiotic resistance. Explaining the causes implies the creation of a new paradigm as the increase and spread of antibiotic resistance becomes a major concern worldwide. Recent studies findings and conclusions about antibiotic resistance genes are reported in the interesting article. Read more

Next CMI issue highlights

June issue editorial:

  • The apes as reservoir of human pathogens, D.Raoult

June issue reviews:

  • Simian retroviruses in African apes, M. Peeters and E.Delaporte
  • Wild great apes as sentinels and sources of infectious disease, S. calvignac-Spencer, S. A. J. Leenderty, T.R. Gillepspie and F. H. Leendertz
  • Ape Plasmodium parasites as a source of human outbreaks, L. Duval and F. Ariey

The outgoing ESCMID president Giuseppe Cornaglia warmly welcomed the incoming ESCMID president Gunnar Kahlmeter on the stage at the Opening Ceremony at the ExCeL Centre in London on the evening of 31 March 2012. Prof Cornaglia, who was two-time president of ESCMID, will be in charge of the role of Communication Officer over the next two years and will work side by side with the newly appointed president Gunnar Kahlmeter and the rest of the Executive Committee.

The European Congress in Clinical Microbiology and Infectious Diseases has just ended and ESCMID is enjoying the fruits of its labour throughout the year. A wonderful Opening Ceremony on Saturday, 31 March took place at the ExCeL Centre in London. Jon Cohen, ECCMID president, opened the Ceremony followed by Jordi Vila, ECCMID programme director, who presented the outstanding statistics to the ECCMID 2012 participants. The outgoing president Giuseppe Cornaglia and the incoming president Gunnar Kahlmeter met on the stage of the Opening Ceremony. Read more 

The international ECCMID attendees had the chance to browse the Manual of Microbiology and buy it in London during the congress. Virtually all copies of the Manual of Microbiology presented at ECCMID were quickly sold at the ESCMID stand within a few days. More copies will be available and advertised on ESCMID website soon. Read more 

Roger Finch, former president of ESCMID, has taken over as ESCMID Guidelines Director. The ESCMID executive would like to thank outgoing Guidelines Director Erdal Akalin for the excellent foundation he has laid during his years in this position, and welcome Roger Finch to the role. During the autumn of 2012, Roger Finch will present his plans for ESCMID Medical Guidelines on the ESCMID website.

The ESCMID team will be the first to reach the ExCel Centre in London in  order to make sure that everything is geared up for your arrival at ECCMID 2012. In the meantime we want to highlight two novel events:

  • Tuesday, 3 April 2012, Late-breaker round table and open discussion: Flu, mutations and transmission: to publish or not
    to publish?
    Discuss personally with Albert Osterhaus, Ron Fouchier, Yoshihiro Kawaoka and colleagues their recent research findings on influenza virus mutations and the implications for public health. 

Fifty-two chapters prepared by over 100 authors and editors have recently been published in hardcover. Grab your copy: it’s available at ECCMID in less than 20 days. The manual covers the main areas of microbiology and represents the most up-to-date knowledge in the field in Europe.

28 March 2012
Social media and mobile application at ECCMID

We are glad to inform you that one of this year’s news at ECCMID will be a mobile application including updates from the ECCMID profiles on Twitter and Facebook. Our press office will also cover the social media, providing information and answering your questions before, during and after the congress.
As interaction is crucial  for ESCMID, the year 2012 marks an important milestone in communication at ECCMID, too, as we are able to provide a direct and privileged communication channel to ECCMID participants.

ECCMID is on Facebook, Twitter, Linkedin, Linkedin events.

The publication of the Manual of Microbiology is one of the latest great achievements of ours, made possible by CM/ID experts from ESCMID and SFM. The publication will be celebrated during the 22nd ECCMID, where the manual will be available for purchase.

Today, 17 February 2012, is the deadline for submitting your abstract. This is the last chance to present your late-breaker abstract and take part in the European Congress of Clinical Microbiology and Infectious Diseases-22nd ECCMID.
Please contact us at for any issue or question regarding the registration.

A couple of months to go before ECCMID 2012, and the final detailed scientific programme is now online. Read through the programme and pick your favourite session, lecture or symposium. ECCMID also offers educational workshops, a TAE Trainees Day and highly interactive Meet-the-Expert sessions held by a representative selection of CM/ID experts. Read more about the 22nd ECCMID scientific programme.

The 2012 recipients of the Excellence Award, Young Investigator Awards, TAE Excellence Training Awards, Research Grants and Training Fellowships have just been selected. You can now discover all those who will be honoured during the forthcoming ECCMID.

Following last year’s success, the next Trainees Day session will take place at ECCMID 2012 on Saturday 31 March. Once again, there will be a highly interactive session for trainees in Clinical Microbiology and Infectious Diseases. All ESCMID members in training are strongly advised not to miss this excellent educational event. More senior members of ESCMID are expected to inform their trainees about it and encourage them to attend.

An important project that involved the Parity Commission in the last year is the creation of the ESCMID guidance on how to balance the scientific programme of ESCMID-related educational events by gender and country of origin. The Parity Commission believes that an improved balance will be reflected by a significant increase in the quality of ESCMID activities overall.
Read more and download the Guidance on How to Balance the Scientific Programme of ESCMID-Related Events.

20 February 2012
ESCMID and ECCMID on social media

The best way to start the year is to keep up with the times: ESCMID and ECCMID are now on social media. As we open our organisation to the new means of communication and interaction, we plan to create ESCMID and ECCMID profiles on several social media platforms so as to reach each and every one of you and many more interesting scientists for you to engage with to expand your professional network, share your insight and exchange opinions. Finally, ESCMID and ECCMID are at your disposal via social media to provide immediate responses to any questions or issues.
Join the conversation:
ESCMID is on Facebook, Twitter, Linkedin.
ECCMID is on Facebook, Twitter, Linkedin, Linkedin events.
Please sign in or sign up to the social media platforms to see and/or to join the ECCMID and ESCMID profiles.

This month the CMI editor chose an article describing the uncontrolled development in the last ten years of extended-spectrum beta-lactamases (ESBLs) among Enterobacteriaceae and the potential harm generated by multiresistance as the number of cabapenemase-producing Enterobacteriaceae increases. In fact, the role of Carbapenem is crucial in the treatment of enterobacterial infections as last line of antibiotics that is still effective.

ESCMID is proud to announce the publication of the Manual of Microbiology, which can be purchased at ECCMID 2012. The Manual is the result of the work and efforts of CM/ID experts from ESCMID and SFM to present a European perspective on Clinical Microbiology.

Haven’t submitted your abstract for ECCMID 2012 yet? Do you have cutting-edge results to present? As a CM/ID leading congress, ECCMID offers you an exceptional opportunity: you may still participate by presenting your late-breaker abstract by 17 February 2012. Don’t pass up the chance!

Young ESCMID members could become the protagonists of the next four years (2012-2016) at ESCMID by joining the the TAE -Trainee Association of ESCMID- Steering Committee, as two places will be vacant in April 2012. The two new members will be elected in February 2012.

If your profile matches the candidate requirements, nominate yourself for the election from 10-31 January 2012.

24 January 2012
TAE newsletter

The January newsletter of the TAE features the association’s latest activities and urges everyone to participate. Here are the stimulating topics: the call for candidates for the TAE Steering Committee Election; the second Trainees’ Day at ECCMID 2012 in London; the online quiz CM & ID; the TAE Excellence in Training Awards 2012, and a clear explanation of what the TAE is. Read more  and get involved in the TAE!

As the author’s article emphasises, the media have been focusing on the topic of the current CMI editor’s choice demonstrating how far the media influence can go. Some studies on the increase in hospitalizations, trends and mortality for bacterial infective endocarditis in the US—mainly caused by S. Aurerus—further aroused media interest in the subject. However, these interesting studies have a shadow side, and this article delves into the story unveiling important information.

24 January 2012
EPASG Newsletter

EPASG has been showing to be a highly active  ESCMID Study Groups since its recent foundation in 2010. Read  news from the ESCMID PK/PD of the Anti-Infectives Study Group in the EPASG January newsletter. Read about the FP7 project AIDA started in 2010; the special issue of Current Opinion in Pharmacology regarding anti-infectives; the EPASG Educational Workshop at ECCMID in London and the two ESCMID Technical Workshops in Madrid and in Athens.

Find: Clinical Microbiology and Infection (CMI), New Microbes & New Infections (NMNI), medical guidelines, ESCMID Yearbook, ESCMID eLibrary, Reports & links.